Benchmark Maintains Buy on Marvell, $135 Price Target

Analyst: Cody Acree 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$135
Unchanged
Outcome
Missed
within 12 months

StoneX’s latest target on Marvell is now $375 (Nov 3, 2026); the median of 23 firms is $300. StoneX has reached 67% of its year-old targets (33 scored).

StoneX and Marvell logos

What the analyst said

Benchmark analyst Cody Acree reiterated a Buy rating and $135.00 price target on Marvell (NASDAQ: MRVL).

“Marvell’s shares dove as much as 15% in after-hours trading, largely driven by its near in-line outlook, with its revenue and EPS guidance being just $10 million and $0.01, respectively, ahead of the consensus versus obviously more elevated investor expectations.

Although we understand the knee-jerk negative trading reaction to less than stellar guidance upside, we believe a certain level of pessimism was already reflected in the company’s shares, which have significantly underperformed NVDA on a one-month and year-to-date basis (MRVL down 17.8% vs NVDA down 6% over the last month and MRVL down 18.4% vs. NVDA down 12.7% year-to-date) and have generally matched AVGO’s performance over both time periods (AVGO down 17.4% one-month and year-to-date).

While the broader AI trade has recently come under fire from increasing investor concerns regarding the impact of tariffs and heighted foreign trading restrictions, we believe there were many encouraging elements of Marvell’s report to improve investors’ enthusiasm for both the name and the AI-space, as a whole.

As such, we recommend investors take advantage of the near-term share price weakness as an opportunity to add to positions at a discount and accordingly reiterate our Buy rating & our $135 price target, or 36x our new FY27 EPS estimate of $3.71, or a two-year average forward PEG of just 0.65x.”

Cite this note: Price Target, "Benchmark Maintains Buy on Marvell, $135 Price Target," March 6, 2025. https://price-target.com/2025/03/06/179179/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $122. The 23 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $135 target is 55% below the median, the lowest on the Street.

Since the note MRVL has moved +36% (from $90.14). The 12-month window closed on March 6, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note MRVL closed at $89.57, 34% below the $135 target, and it moved the other way.

Firm track recordStoneX: 67% of its 33 targets at least a year old were reached within 12 months (#27 of 29 firms). Accuracy ranking →

StoneX on Marvell

StoneX price targets on Marvell

8 calls from March 6, 2025 to November 3, 2026. The target went from $135 to $375 (+178%). The rating stayed Buy.

StoneX targetMRVL share price
  1. November 3, 2026Kept the $375 targetBuy$375
  2. October 7, 2026Target raised from $275 (+36%)Buy$375
  3. August 28, 2026Kept the $275 targetBuy$275
  4. August 24, 2026Kept the $275 targetBuy$275
  5. May 28, 2026Target raised from $130 (+112%)Buy$275
  6. March 6, 2026Upgraded to Buy, target cut from $135 (−4%)Buy$130
  7. February 3, 2026Downgraded to HoldHoldNo target
  8. March 6, 2025 This noteEarliest call shownBuy$135
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.